West Pharmaceutical Services Inc

NYSE: WST
$321.97
+$1.09 (+0.3%)
Real Time Data Delayed 15 Min.

WST Stock Chart and Intraday Price

WST Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector MANUFACTURING
Industry FABRICATED RUBBER PRODUCTS, NEC
Address 530 HERMAN O. WEST DRIVE, EXTON, PA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 26,293.92M USD
Shares Outstanding 73,299,000
West Pharmaceutical Services Inc specializes in creating containment and delivery systems for injectable drugs and healthcare products. With a global presence, it offers a wide range of products including stoppers, seals, syringe components, and advanced drug delivery systems. The company focuses on enhancing the safety and quality of drug administration through innovative solutions like Crystal Zenith technology and self-injection devices. Serving the pharmaceutical, diagnostic, and medical device industries, West Pharmaceutical provides both proprietary and contract-manufactured products, backed by comprehensive support services from development to post-sales.

WST Articles

Tuesday's top analyst upgrades and downgrades included Activision Blizzard, Adobe, Advanced Micro Devices, Ares Capital, Intel, Lennar, Marvell Technology, NexTier Oilfield Solutions, Nike, Nvidia,...
Wednesday's top analyst upgrades and downgrades included Antero Resources, Array Technologies, Bumble, Chewy, EQT, LendingClub, Match, MGIC Investment, Nasdaq, New York Community Bancorp, Palo Alto...
The big U.S. indexes traded lower in Friday's premarket, continuing the prior day's trend, and short-term bonds seem to be the place to be.
Monday's top analyst upgrades and downgrades included Altria, Amazon.com, Apple, Axalta Coating Systems, Comcast, Etsy, Intel, McDonald's and Medical Properties Trust.
The S&P 500 index is up about 2% this year, after a spring collapse and remarkable rebound. Among the companies in the index, 10 are up more than 50%.
Thursday's top analyst upgrades, downgrades and initiations included Autodesk, Bausch Health, Charles Schwab, Darden Restaurants, Garmin, GE, Home Depot, Kroger, Merit Medical and Starbucks.
Analysts at Jefferies recently reviewed several pharmaceutical services company stocks and put a Buy rating on four outstanding performers.
These stocks offer investors strength in their specific industries and the ability to avoid high-flying disasters. All of them are suitable for growth accounts with some degree of risk tolerance.
The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest and Wendy's.
Over the past five, 10 and 20 years, the life science and bioproduction segments have tended to outperform the S&P 500 more often than not.
The top analyst upgrades, downgrades and initiations seen on Friday morning include AK Steel, Alphabet, Amazon, Boeing, ConocoPhilllips, Nokia and Twitter.
The top analyst upgrades, downgrades and initiations seen on Monday morning include AmSurg, Invesco, Monsanto, NetApp, Twitter, Ericsson and Pentair.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Altria, Barclays, E*Trade, Petrobras, Range Resources, Vale, Etsy, Jabil Circuit and Wix.com.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Baidu, Enterprise Products Partners, Kinder Morgan, Kinross Gold, Marketo, Office Depot, Staples, Walt Disney,...
The top analyst upgrades, downgrades and initiations seen on Tuesday, March 22, include Amazon.com, Chevron, Monster Beverage, Range Resources, Wayfair, Wynn Resorts and Yahoo.